杰夫·沃莱克博士（ Dr.Jeff Volek）是 Virta Health 健康机构的首席科学官和联合创始人，这是第一个经过临床验证的治疗方法，无需药物或手术即可安全、可持续地逆转 2 型糖尿病。
在过去的二十年里，杰夫·沃莱克博士对人类如何适应限制碳水化合物的饮食进行了前沿研究，同时关注营养性生酮的临床和功能的应用。他的学术著作包括 300 多篇经同行评审的科学论文和五本书，其中包括《纽约时报》畅销书，他也在世界各地的科学和行业会议上提供了 200 多场讲座。 沃莱克博士是《低碳水化合物生活的艺术与科学》和《低碳水化合物表现的艺术与科学》一书的作者，这两本关于低碳水化合物营养科学和营养酮症的基础书籍是他与医学博士斯蒂芬.菲尼合着的。
作为俄亥俄州立大学人类科学系的注册营养师和教授，沃莱克博士的工作为现有的酮类和生酮饮食科学做出了贡献，将它们用作管理胰岛素抵抗的治疗工具，以及它们日益增长的潜力增强人类的应变能力。这项工作显示了碳水化合物限制对整体健康和福祉的深远影响，他积累了大量的实验室和临床数据，涉及生物标志物的发现和个性化、有效和可持续的低碳水化合物配方饮食。
他在俄亥俄州立大学的团队目前专注于做出新发现并开辟与营养性酮症相关的新应用。这些研究正在探索营养性酮症对心脏代谢状态、各种组织（肝脏、肌肉、心脏）的异位脂肪积累、晚期乳腺癌女性的肿瘤代谢和健康结果以及军事人员的身体和认知能力的作用.
沃莱克博士不只是写他的研究——他亲自使用它。作为一名前运动员和竞技举重运动员，他遵循低碳水化合物饮食的原则，同时定期进行力量和健康训练。
沃沃莱克博士拥有密歇根州立大学的营养学理学学士学位、宾夕法尼亚州立大学的运动生理学理学硕士学位和运动机能学和营养学博士学位。
沃莱克博士：关于他的工作和研究
Jeff Volek is the Chief Science Officer and Co-Founder of Virta Health, the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without medications or surgery.
For the last two decades, Dr. Volek has performed cutting edge research on how humans adapt to diets restricted in carbohydrates with a dual focus on clinical and performance applications of nutritional ketosis. His scholarly work includes more than 300 peer-reviewed scientific manuscripts and five books, including a New York Times Best Seller, and he has provided more than 200 lectures at scientific and industry conferences around the world. Dr. Volek is the author of The Art and Science of Low Carbohydrate Living and The Art and Science of Low Carbohydrate Performance, two foundational books on low carb nutrition science and nutritional ketosis that he wrote with Stephen Phinney, MD, Ph.D.
As a registered dietitian and professor in the Department of Human Sciences at The Ohio State University, Dr. Volek’s work has contributed to the existing science of ketones and ketogenic diets, their use as a therapeutic tool to manage insulin resistance, plus their increasing potential to augment human resiliency. This line of work has shown profound effects of carbohydrate restriction on overall health and well-being, and he has accumulated an extensive amount of laboratory and clinical data as it pertains to biomarker discovery and the formulation of personalized, effective, and sustainable low-carbohydrate diets.
His team at Ohio State University is currently focused on making new discoveries and breaking open new application related to nutritional ketosis. These studies are exploring the role of nutritional ketosis on cardio-metabolic status, ectopic fat accumulation in various tissues (liver, muscle, heart), tumor metabolism and health outcomes in women with advanced breast cancer, and human physical and cognitive capabilities in military personnel.
Dr. Volek does not just write about his research—he personally uses it. A former athlete and competitive powerlifter, he follows the principles of a low carbohydrate diet while regularly training for strength and health.
Dr. Volek has a Bachelor of Science in dietetics from Michigan State University, and a Master of Science in exercise physiology and Doctorate in kinesiology and nutrition from Pennsylvania State University.
官网：https://www.virtahealth.com/people/jeff-volek
学术报告：
Saturated Fats and Health A Reassessment and Proposal for Food-Based Recommendations
美国俄亥俄州立大学任教信息：
Jeff S. Volek，博士，R.D. 教授
人体科学系
volek.1@osu.edu
(614) 688-1701
Jeff Volek 博士是俄亥俄州立大学人文科学系的教授。作为世界知名的低碳水化合物研究专家，Volek 博士专注于生酮饮食的临床应用，尤其是胰岛素抵抗和 2 型糖尿病的管理，以及运动表现和恢复。他的研究旨在了解个体差异，包括生酮饮食如何改变脂肪酸组成、脂蛋白代谢、肠道微生物组、基因表达、对训练的适应和整体代谢健康。他进行了几项前瞻性饮食研究，证明精心配制的生酮饮食可以显着改善（如果不是完全逆转）代谢综合征和 2 型糖尿病。在过去的 15 年中，Volek 博士获得了超过 700 万美元的研究资助，并积累了大量的实验室和临床数据，这些数据与生物标志物的发现和个性化、有效和可持续的低碳水化合物饮食的制定有关。除了研究之外，Volek 博士还开展了多项旨在将低碳水化合物科学向公众传播的举措，包括他担任 Keto Thrive Corp 首席科学家的角色。他还在包括肌酸、肉碱和乳清蛋白在内的膳食补充剂方面开展了开创性的工作。他已受邀在八个国家的科学和工业会议上就他的研究发表演讲超过 150 次。他的学术著作包括 280 篇经过同行评审的科学手稿和 5 本书，其中包括一本《纽约时报》畅销书，总销量超过 700 万册。
Jeff S. Volek, Ph.D., R.D.
Professor
Department of Human Sciences
volek.1@osu.edu
(614) 688-1701
Website
Dr. Jeff Volek is a Professor in the Department of Human Sciences at The Ohio State University. A world-renowned expert in low carbohydrate research, Dr. Volek focuses on the clinical application of ketogenic diets, especially the management of insulin resistance and type-2 diabetes, as well as athletic performance and recovery. His research aims to understand individual variability including how ketogenic diets alter fatty acid composition, lipoprotein metabolism, gut microbiome, gene expression, adaptations to training and overall metabolic health. He has performed several prospective diet studies that demonstrate that well-formulated ketogenic diets result in substantial improvements in (if not complete reversal of) metabolic syndrome and type-2 diabetes. Dr. Volek has garnered over $7 million in research grants over the last 15 years, and accumulated an enormous amount of laboratory and clinical data as it pertains to biomarker discovery and formulation of personalized, effective and sustainable low carbohydrate diets. In addition to research, Dr. Volek has several initiatives aimed at translating low-carbohydrate science to the public including his role as Chief Scientist of KetoThrive Corp. He has also performed seminal work on dietary supplements including creatine, carnitine, and whey protein. He has been invited to lecture on his research more than 150 times at scientific and industry conferences in eight countries. His scholarly work includes 280 peer-reviewed scientific manuscripts and 5 books, including a New York Times Best Seller, collectively selling over 700 hundred thousand copies.
